Cardiovascular Diabetology

Academic journal

Academic journal

Cardiovascular Diabetology

Discipline| Cardiology, diabetology
Language| English
Edited by| Enrique Fisman
Publication details
History| 2002-present
Publisher|

BioMed Central

Open access

| Yes
License| Creative Commons Attribution

Impact factor

| 9.3 (2022)
Standard abbreviations
ISO 4 (alt) * Bluebook (alt)
NLM (alt) * MathSciNet (alt )
ISO 4| Cardiovasc. Diabetol.
Indexing
CODEN (alt * alt2) * JSTOR (alt) * LCCN (alt)
MIAR * NLM (alt) * Scopus
ISSN| 1475-2840

OCLC no.| 848273564
Links

* Journal homepage
* Online access

Cardiovascular Diabetology is a peer-reviewed open access medical journal covering the intersection of cardiology and diabetology, meaning the connection between diabetes, metabolic syndrome and cardiovascular diseases. It is published by BioMed Central (a part of Springer Nature since 2008) and was established in 2002, with Enrique Fisman (Tel Aviv University) and Alexander Tenenbaum (Sheba Medical Center) as founding editors-in-chief. Alexander Tenenbaum died in 2022.

## Scope

[edit]

Cardiovascular Diabetology considers for publications manuscripts on all aspects of the diabetes/cardiovascular interrelationship, including clinical, genetic, experimental, pharmacological, epidemiological, molecular biology and laboratory research. Seven article types maybe considered for publication: original investigations, reviews, case reports, commentaries, hypotheses, methodology articles and study protocols; most of published papers are original investigations. Articles are published online upon acceptance, rather than in issues. A printed version is periodically distributed in India by Panacea Biotec Ltd.

## Abstracting and indexing

[edit]

The journal is abstracted and indexed in Chemical Abstracts Service (CAS), Citebase, Current Contents, Directory of Open Access Journals (DOAJ), EMBASE, MEDLINE/PubMed, Science Citation Index, SCImago Journal Rank, Scopus and Socolar.[1] According to the Journal Citation Reports, the journal has a 2022 impact factor of 9.3, ranking it in the 93.1 JIF percentile (10 out of 145 journals) in the category of "Endocrinology & Metabolism", and in the 88.7 JIF percentile (16 out of 142 journals) in the category "Cardiac & Cardiovascular Systems" journals.[2]

## References

[edit]

1. ^ "About". BioMed Central. Retrieved 16 October 2020.
2. ^ "Cardiovascular Diabetology". 2023 Journal Citation Reports. Web of Science (Science ed.). Clarivate Analytics. 2022.

## External links

[edit]

* Official website

This article about a cardiology journal is a stub. You can help Wikipedia by expanding it.

See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page.

|

* v
* t
* e

*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template